Healthy volunteers help test safety of experimental hypertension and diabetes drug
NCT ID NCT07598968
First seen May 31, 2026 · Last updated Jun 12, 2026 · Updated 1 time
Summary
This early-stage trial tested two versions of an experimental drug (HL1113) in 35 healthy adults to see how safe they are and how the body processes them. The study did not aim to treat any disease, but to gather important safety and drug-level information for future research. Participants took multiple doses of each version in a crossover design, allowing direct comparison.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Central Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.